JPRN-UMIN000012640
Completed
未知
Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patients - Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patients(Dose Flex Study)
Clinical Research Support Center Kyushu0 sites100 target enrollmentDecember 20, 2013
ConditionsOveractive bladder
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Overactive bladder
- Sponsor
- Clinical Research Support Center Kyushu
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients with contraindications for imidafenacin 2\)Patients who have current condition of severe difficulty of urination 3\)Patients who have history of urinary retention 4\)Patients with serious kidney dysfunction 5\)Residual urine volume \> 50 mL 6\)Patients with cancer in bladder, cystoliths, urinary tract infection, recurrent urinary tract infection or interstitial cystitis 7\)Patients with polyuria 8\)Patients who have administered prohibited substances or done prohibited therapy in the 4 weeks prior to the start of study (excepting operations on urinary and sexual organs) 9\)Patients who have been operated on the urinary or sexual organs in the 6 months prior to the start of study 10\)Patients with unstable lower urinary tract symptoms 11\)Any other patients who are regarded as unsuitable for this study by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)ot applicableJPRN-UMIN000051748Suntory Wellness Limited200
Completed
Phase 4
Intranasal ketamine for moderate to severe pain in children- a dose finding study.acute painmusculoskeletal injuryAnaesthesiology - Pain managementInjuries and Accidents - Other injuries and accidentsACTRN12612000012875Southern Health60
Completed
Not Applicable
Clinical dose-finding study to assess the effect of ABAlifeTM on postprandial blood glucose profile in prediabetic subjects: randomized, multicentric, double-blind, placebo-controlled, cross-over study with different dosages combined with a 12-weeks follow-up phasePre-DiabetesDRKS00026093Anton Hübner GmbH & Co. KG61
Terminated
Phase 2
To identify the effective dose(s) of RT234 (vardenafil inhalation powder) to acutely improve pulmonary vascular haemodynamics in study participants with Pulmonary Arterial Hypertension (PAH).Pulmonary Arterial HypertensionCardiovascular - Other cardiovascular diseasesACTRN12619001178134Respira Therapeutics Australia Pty Ltd14
Completed
Not Applicable
Verification of the efficacy and effective dose of dietary fibers on postprandial blood glucose elevatioHealthy adultsJPRN-UMIN000034771KAGOME CO., LTD.14